Sachem Capital Corp. 6.00% Notes Due 2026
Sachem Capital Corp. 6.00% Notes Due 2026 (SCCD) Financial Performance & Income Statement Overview
Review Sachem Capital Corp. 6.00% Notes Due 2026 (SCCD) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Sachem Capital Corp. 6.00% Notes Due 2026 (SCCD) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Sachem Capital Corp. 6.00% Notes Due 2026 SCCD financial performance.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $10.78M | $11.44M | $25.84M | $14.79M |
| Cost of Revenue | $0.00 | $0.00 | $15.18M | $290000.00 |
| Gross Profit | $0.00 | $11.44M | $10.67M | $14.49M |
| Gross Profit Ratio | $0.00 | $1.00 | $0.41 | $0.98 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.30M | $1.35M | $678426.00 | $2.30M |
| Operating Expenses | $9.71M | $10.41M | $678426.00 | $19.32M |
| Total Costs & Expenses | $0.00 | $10.41M | $40.52M | $19.61M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $1.17M | $0.00 |
| EBITDA | $1.07M | $1.03M | $4.28M | -$4.82M |
| EBITDA Ratio | $0.10 | $0.09 | $0.17 | -$0.33 |
| Operating Income | $1.07M | $1.03M | -$14.67M | -$22.60M |
| Operating Income Ratio | $0.10 | $0.09 | -$0.57 | -$1.53 |
| Other Income/Expenses (Net) | -$297000.00 | -$1.24M | -$23.65M | $16.45M |
| Income Before Tax | $769000.00 | -$213000.00 | -$38.32M | -$6.15M |
| Income Before Tax Ratio | $0.07 | -$0.02 | -$1.48 | -$0.42 |
| Income Tax Expense | $0.00 | $0.00 | -$42.85M | $0.00 |
| Net Income | $769000.00 | -$213000.00 | -$36.13M | -$6.15M |
| Net Income Ratio | $0.07 | -$0.02 | -$1.40 | -$0.42 |
| EPS | $0.02 | -$0.005 | $0.11 | -$0.10 |
| Diluted EPS | $0.02 | -$0.005 | $0.15 | -$0.14 |
| Weighted Avg Shares Outstanding | $46.88M | $46.78M | $58.89M | $58.89M |
| Weighted Avg Shares Outstanding (Diluted) | $46.88M | $44.24M | $44.24M | $44.24M |
Financial performance has remained strong, with revenue growing from $14.79M in Q3 2024 to $10.78M in Q2 2025. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached $1.07M in Q2 2025, holding a steady 10% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $1.07M. Net income rose to $769000.00, keeping EPS at $0.02. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan